Unknown NA INTERVENTIONAL 2-arm NCT02056379

Comparison Between Budesonide and Dexamethasone Treatments for Respiratory Discomfort After Extubation on Children (BUDEXA)

Comparison Between Inhaled Budesonide and Intravenous Dexamethasone Treatments for Postextubation Stridor in Children

Sponsor: Hospital Israelita Albert Einstein

Conditions Stridor

Updated 5 times since 2017 Last updated: Feb 4, 2014 Started: Mar 31, 2014 Primary completion: Mar 31, 2015 Completion: Mar 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02056379, this NA trial focuses on Stridor and remains ongoing. Sponsored by Hospital Israelita Albert Einstein, it has been updated 5 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Israelita Albert Einstein
Hospital M'Boi Mirim

Data source: Hospital Israelita Albert Einstein

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• São Paulo, Brazil